MTOR and hereditary hemorrhagic telangiectasia: Our data indicate that the HHT-like phenotype in zebrafish eng mutants can be mitigated through modulation of Vegf signalling and implicate synergistic targeting of ERK and mTOR pathways as a therapeutic strategy in HHT.